R Strauss

Summary

Affiliation: University of Erlangen-Nuremberg
Country: Germany

Publications

  1. ncbi request reprint Pseudomembranous tracheobronchitis due to Bacillus cereus
    R Strauss
    Department of Medicine I, University of Erlangen Nuremberg, Erlangen, Germany
    Clin Infect Dis 33:E39-41. 2001
  2. ncbi request reprint Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems
    M Wehler
    Department of Medicine I and Medical Informatics, University of Erlangen Nuremberg, Germany
    Hepatology 34:255-61. 2001
  3. ncbi request reprint Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement
    J Rech
    Department of Internal Medicine III, University of Erlangen Nuremberg, 91054, Erlangen, Germany
    Clin Rheumatol 26:112-4. 2007

Detail Information

Publications3

  1. ncbi request reprint Pseudomembranous tracheobronchitis due to Bacillus cereus
    R Strauss
    Department of Medicine I, University of Erlangen Nuremberg, Erlangen, Germany
    Clin Infect Dis 33:E39-41. 2001
    ..To our knowledge, this is the first report of a B. cereus infection that has caused pseudomembranous tracheobronchitis, possibly because of the production of bacterial toxins...
  2. ncbi request reprint Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems
    M Wehler
    Department of Medicine I and Medical Informatics, University of Erlangen Nuremberg, Germany
    Hepatology 34:255-61. 2001
    ..The SOFA is an easily applied tool with excellent prognostic abilities and can be used to enhance clinical judgment of prognosis as well as providing patients and families with objective information...
  3. ncbi request reprint Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schönlein purpura with disseminated organ involvement
    J Rech
    Department of Internal Medicine III, University of Erlangen Nuremberg, 91054, Erlangen, Germany
    Clin Rheumatol 26:112-4. 2007
    ..One year after discharge, the patient is doing well without any signs of activity of HSP and completely unremarkable renal function. The maintenance daily dose of steroids is 7.5 mg...